Última actualización: Agosto 17, 2026
- Osteoartritis
Intravenous infusion of autologous MSCs has shown positive results in osteoarthritis by reducing joint pain, mejorando la movilidad, and decreasing inflammation. Patients often experience improved cartilage preservation and less joint stiffness. The mechanisms include immunomodulation through secretion of anti-inflammatory cytokines, paracrine effects stimulating cartilage repair, and inhibition of catabolic enzymes that degrade cartilage matrix. MSCs home to inflamed joints via systemic circulation and promote tissue regeneration while suppressing chronic inflammation. - Artritis reumatoide
MSC therapy can significantly alleviate symptoms of rheumatoid arthritis, such as joint swelling, dolor, y rigidez. Improvements include better joint flexibility and reduced need for immunosuppressive drugs. MSCs work by modulating the overactive immune response, decreasing pro-inflammatory cytokines (como TNF-α e IL-6), promoting regulatory T-cell activation, and directly suppressing autoreactive lymphocytes. Their systemic anti-inflammatory actions help protect joint structures from further damage. - Espondiloartritis anquilosante
Patients with ankylosing spondylitis benefit from MSC infusions through decreased spinal stiffness, reducción del dolor, and improved flexibility. MSCs exert effects by targeting systemic inflammation, secreting anti-inflammatory factors, and modulating Th17/Treg cell balance. Además, MSCs reduce fibrosis in spinal ligaments and help maintain vertebral mobility. Their ability to home to sites of inflammation through chemokine signals ensures targeted therapeutic action. - Artritis psoriásica
MSC therapy offers relief for psoriatic arthritis, leading to reduced joint pain, improved skin conditions, and better mobility. mecanicamente, MSCs downregulate Th17-driven inflammatory pathways, suppress keratinocyte hyperproliferation, and enhance skin repair via paracrine signaling. By migrating to inflamed tissues, MSCs not only protect joints but also improve skin lesions associated with psoriasis, contributing to an overall improvement in quality of life. - Lupus eritematoso sistémico (LES)
In SLE, MSC infusions lead to reduced systemic inflammation, improved skin health, and decreased joint pain. MSCs achieve this by suppressing autoreactive B and T cells, increasing regulatory T cell populations, and reducing production of pathogenic autoantibodies. Through homing to inflamed organs, MSCs stabilize immune activity and promote tissue repair, particularly in kidneys, piel, and joints affected by lupus.
Revisión de casos científicos
¿Le gustaría saber si los programas clínicos actuales, desarrollos recientes de investigación, o enfoques emergentes pueden ser relevante para su situación individual?
Envía tu pregunta a nuestro equipo científico. La oficina central de NBScience en el Reino Unido coordina consultas a través de la red internacional de centros médicos, científicos, y consultores especializados.
- Revisión de la información que proporcionas.
- Información relevante sobre programas clínicos y de investigación.
- Una respuesta clara y centrada en tu situación.
¿Qué pasa después??
Envía tu pregunta, recibir una revisión científica enfocada, y obtenga una respuesta clara sobre la investigación y los programas clínicos relevantes para su situación.
Su revisión científica será preparada por Dr. Helen Mélnik,Doctor en Filosofía , quien tiene más de 25 años de experiencia en investigación de células madre y programas clínicos internacionales.
Sin compromiso. Su pregunta será revisada de forma confidencial..
Información educativa y de investigación únicamente.. Este servicio no constituye consejo médico, diagnóstico, prescripción, o un personalizado recomendación de tratamiento.
